Clinical Trial Update: A Study in Participants With End-Stage Renal Disease [Phase 2]

View source ↗

Summary

Phase 2 trial in participants with end-stage renal disease has completed; results were posted on 2018-05-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Eli Lilly and Company | Conditions: Kidney Failure, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2018-05-14